PUREGON

This brand name is authorized in Austria, Australia, Canada, Cyprus, Estonia, Spain, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, South Africa

Active ingredients

The drug PUREGON contains one active pharmaceutical ingredient (API):

1 Follitropin beta UNII 076WHW89TW - FOLLITROPIN

Follitropin beta is a recombinant FSH. Follitropin beta can be used to stimulate follicular development and steroid production in selected cases of disturbed gonadal function. Furthermore follitropin beta can be used to promote multiple follicular development in medically assisted reproduction programs. Read about Follitropin beta

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PUREGON Solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03GA06	Follitropin beta	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03G Gonadotropins and other ovulation stimulants → G03GA Gonadotropins
Discover more medicines within G03GA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 6335K, 6336L, 6464F, 8565T, 8566W, 8871X
Country: CA	Health Products and Food Branch	Identifier(s): 02243948
Country: EE	Ravimiamet	Identifier(s): 1011913, 1011924, 1011935, 1064045, 1064056, 1064067, 1064078, 1064089, 1064090, 1099335, 1099403, 1209923, 1209934, 1209945, 1209956, 1209967, 1209978, 1209989, 1209990, 1210004, 1215100, 1215111
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 96008025, 96008038, 96008039, 96008041
Country: FR	Base de données publique des médicaments	Identifier(s): 60727755, 62448341, 65214799, 65393373
Country: HK	Department of Health Drug Office	Identifier(s): 51208, 51209, 55493
Country: IE	Health Products Regulatory Authority	Identifier(s): 88761, 88762, 88820, 88833
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4733, 4734, 4965
Country: IT	Agenzia del Farmaco	Identifier(s): 029520018, 029520020, 029520032, 029520044, 029520057, 029520069, 029520071, 029520083, 029520095, 029520107, 029520119, 029520121, 029520133, 029520145, 029520158, 029520160, 029520172, 029520184, 029520196, 029520208, 029520210, 029520222, 029520234, 029520246, 029520259, 029520261, 029520273, 029520285, 029520297, 029520309, 029520311, 029520323, 029520335, 029520347, 029520350, 029520362, 029520374, 029520386, 029520398, 029520400
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1007032, 1007033, 1007034, 1007035, 1007036, 1007037, 1007038, 1007039, 1007040, 1008120, 1008121, 1030534, 1030535, 1030536, 1030537, 1030538, 1030539, 1030540, 1030547, 1030548, 1030549, 1030550
Country: NL	Z-Index G-Standaard	Identifier(s): 14571420, 14571439, 15033163, 15294072, 15294080
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 64270, 64289, 77410, 84034, 84042
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 8909
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100103866, 100103872, 100145712, 100145729, 100296500, 100313990, 100314008, 100314014, 100314020, 100314037
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67765001, W67766001
Country: SG	Health Sciences Authority	Identifier(s): 12183P, 12184P, 12185P, 14473P, 14474P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8683280337367, 8683280337374, 8699636791141
Country: ZA	Health Products Regulatory Authority	Identifier(s): 32/21.10/0311, 32/21.10/0312, 32/21.10/0313